Germany
Japan
United Kingdom
China
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Research Areas
DownloadUSD 475.00
2 Weeks
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
USD 399.00
In Stock
CD13 (ANPEP) mouse monoclonal antibody, clone WM15, Purified
| Applications | ELISA, FC, FN, IHC, IP |
| Reactivities | Human, Primate |
CD130 (IL6ST) mouse monoclonal antibody, clone B-P4, Azide Free
| Applications | FC, FN, IHC, IP, WB |
| Reactivities | Human |
IL3RA mouse monoclonal antibody, clone 6H6, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
CD16 (FCGR3A) mouse monoclonal antibody, clone DJ130c, Purified
| Applications | FC, IHC |
| Reactivities | Human |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Purified
| Applications | ELISA, FC, IF, IHC, IP |
| Reactivities | Bovine, Feline, Human, Monkey, Primate |
HLA Class I ABC mouse monoclonal antibody, clone W6/32, Low Endotoxin
| Applications | ELISA, FC, FN, IF, IHC, IP |
| Reactivities | Bovine, Chimpanzee, Feline, Human, Macaque, Monkey, Primate, Baboon |
CD34 mouse monoclonal antibody, clone ICO-115, PE
| Applications | FC, IF |
| Reactivities | Human, Rat |
| Conjugation | PE |
USD 440.00
2 Weeks
TNFRSF1B mouse monoclonal antibody, clone utr1, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human |
CD4 mouse monoclonal antibody, clone B-A1, Azide Free
| Applications | FC, FN, IHC |
| Reactivities | Human |
CD8A rat monoclonal antibody, clone YTC182.20, Purified
| Applications | FC, IHC |
| Reactivities | Human, Monkey |
CD45 (PTPRC) (CD45RB) mouse monoclonal antibody, clone MEM-55, Purified
| Applications | FC, IHC, IP |
| Reactivities | Human, Primate |
IL6R mouse monoclonal antibody, clone B-R6, Azide Free
| Applications | FC, FN, IHC, IP |
| Reactivities | Human |
USD 745.00
5 Days
Tumor necrosis factor (TNF-alpha) rat monoclonal antibody, clone MP6-XT22, Low Endotoxin
| Applications | ELISA, FC, FN, IHC |
| Reactivities | Mouse, Rat |
Feline Coronavirus mouse monoclonal antibody, clone FIPV3-70, Purified
| Applications | ELISA, FC, IF, IHC, WB |
IL2 Receptor alpha (IL2RA) mouse monoclonal antibody, clone MEM-181, FITC
| Applications | FC |
| Reactivities | Human |
| Conjugation | FITC |
Il6ra mouse monoclonal antibody, clone B-F19, Azide Free
| Applications | FC, FN |
| Reactivities | Human |
IL6 mouse monoclonal antibody, clone B-E8, Azide Free
| Applications | ELISA, FC, FN |
| Reactivities | Human |
CD20 (MS4A1) mouse monoclonal antibody, clone NKI-B20/1, Purified
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Human |
CD45 (PTPRC) (CD45RC) mouse monoclonal antibody, clone MT2, Aff - Purified
| Applications | FC, IF, IHC |
| Reactivities | Human |
CD21 (CR2) mouse monoclonal antibody, clone BB6-11C9.6, Purified
| Applications | FC, IHC, IP |
| Reactivities | Porcine |
CD283 / TLR3 mouse monoclonal antibody, clone TLR3.7, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Mouse |
USD 300.00
In Stock
Integrin alpha E (ITGAE) mouse monoclonal antibody, clone B-ly7, Aff - Purified
| Applications | FC, IHC |
| Reactivities | Human |
CD2 mouse monoclonal antibody, clone LT2, Azide Free
| Applications | FC, FN, IHC, IP |
| Reactivities | Chimpanzee, Human, Monkey |
CD45 (PTPRC) (CD45RB) mouse monoclonal antibody, clone MEM-55, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Human, Primate |
MHC Class II mouse monoclonal antibody, clone 2G11, Purified
| Applications | FC, IHC, IP, WB |
| Reactivities | Chicken |
HLA DM (HLA-DMA) rat monoclonal antibody, clone M5/114, Azide Free
| Applications | FC, FN, IHC, IP, WB |
| Reactivities | Mouse |
Tnfrsf1b rat monoclonal antibody, clone HM102, Aff - Purified
| Applications | ELISA, FC, IHC, IP |
| Reactivities | Mouse |
Active filters
Applications
- FC
Clonalities
- Monoclonal
Filter by
Target Symbol
- PECAM1 (78)
- PDCD1 (66)
- CD5 (58)
- PTPRC (57)
- CD99 (54)
- TNFRSF8 (47)
- CD19 (45)
- CD2 (39)
- IL2RA (32)
- CD33 (26)
- IL3RA (26)
- MME (26)
- CD4 (24)
- CD274 (21)
- CD34 (21)
- CD8A (21)
- ANAPC2 (20)
- CD14 (18)
- CD79B (15)
- FCGR1A (15)
- FCER2 (14)
- CD3E (12)
- TNF (11)
- CD68 (10)
- PTK7 (10)
- IL6ST (8)
- CD74 (6)
- FCGR3A (6)
- TYRO3 (6)
- CD79A (5)
- IL6RA (5)
- MS4A1 (5)
- CD7 (4)
- ITGA2B (4)
- KIT (4)
- CD1A (3)
- CD22 (3)
- CR2 (3)
- IL36A (3)
- IL6 (3)
- IL6R (3)
- CD46 (2)
- HLA CLASS II (2)
- TLR2 (2)
- AGTPBP1 (1)
- BRAF (1)
- CD30 (1)
- ELK3 (1)
- HLA-G (1)
- ITGAE (1)
- ITGB3 (1)
- MAP2K2 (1)
- MAP2K4 (1)
- PRKCE (1)
- RAB3IL1 (1)
- RACK1 (1)
- ROR2 (1)
- SH3GL1 (1)
- TLR3 (1)
- TLR4 (1)
- TLR5 (1)
- TLR6 (1)
- TLR9 (1)
- TMED1 (1)
- WNT5B (1)
Reactivities
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (10)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
Assay Types
Families
- Transmembrane (727)
- Druggable Genome (710)
- ES Cell Differentiation/IPS (282)
- Adult stem cells (71)
- Secreted Protein (61)
- Phosphatase (56)
- Stem cell - Pluripotency (47)
- Embryonic stem cells (41)
- Protease (25)
- Protein Kinase (25)
- Cancer stem cells (19)
- Induced pluripotent stem cells (11)
- Transcription Factors (9)
Pathways
- Cell adhesion molecules (CAMs) (361)
- Hematopoietic cell lineage (348)
- T cell receptor signaling pathway (167)
- Primary immunodeficiency (136)
- Leukocyte transendothelial migration (132)
- Cytokine-cytokine receptor interaction (110)
- Fc gamma R-mediated phagocytosis (76)
- B cell receptor signaling pathway (64)
- Jak-STAT signaling pathway (55)
- Toll-like receptor signaling pathway (35)
- Alzheimer's disease (32)
- Antigen processing and presentation (31)
- MAPK signaling pathway (29)
- Apoptosis (28)
- Endocytosis (28)
- Systemic lupus erythematosus (27)
- Renin-angiotensin system (24)
- Regulation of actin cytoskeleton (23)
- Progesterone-mediated oocyte maturation (21)
- Cell cycle (20)
- Oocyte meiosis (20)
- Pathogenic Escherichia coli infection (20)
- Ubiquitin mediated proteolysis (20)
- Natural killer cell mediated cytotoxicity (17)
- Hypertrophic cardiomyopathy (HCM) (12)
- Fc epsilon RI signaling pathway (11)
- Graft-versus-host disease (11)
- Dilated cardiomyopathy (10)
- Lysosome (10)
- NOD-like receptor signaling pathway (10)
- Pathways in cancer (10)
- Allograft rejection (9)
- Type I diabetes mellitus (9)
- Type II diabetes mellitus (9)
- Adipocytokine signaling pathway (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Asthma (8)
- RIG-I-like receptor signaling pathway (8)
- TGF-beta signaling pathway (8)
- Acute myeloid leukemia (6)
- Melanogenesis (6)
- Complement and coagulation cascades (5)
- ErbB signaling pathway (3)
- Focal adhesion (3)
- Prion diseases (3)
- Vascular smooth muscle contraction (3)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Bladder cancer (2)
- Chronic myeloid leukemia (2)
- Cytosolic DNA-sensing pathway (2)
- ECM-receptor interaction (2)
- Endometrial cancer (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- Melanoma (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Prostate cancer (2)
- Renal cell carcinoma (2)
- Thyroid cancer (2)
- Autoimmune thyroid disease (1)
- Basal cell carcinoma (1)
- Chemokine signaling pathway (1)
- Colorectal cancer (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Gap junction (1)
- Hedgehog signaling pathway (1)
- Pancreatic cancer (1)
- Small cell lung cancer (1)
- Tight junction (1)
- VEGF signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)
- mTOR signaling pathway (1)